4.4 Editorial Material

A novel mouse model provides insights into the neutropenia associated with the ribosomopathy Shwachman-Diamond syndrome

Journal

HAEMATOLOGICA
Volume 100, Issue 10, Pages 1237-1239

Publisher

FERRATA STORTI FOUNDATION
DOI: 10.3324/haematol.2015.133777

Keywords

-

Categories

Funding

  1. European Research Council [334946] Funding Source: Medline
  2. European Research Council (ERC) [334946] Funding Source: European Research Council (ERC)

Ask authors/readers for more resources

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.4
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Hematology

Single-cell DNA amplicon sequencing reveals clonal heterogeneity and evolution in T-cell acute lymphoblastic leukemia

Llucia Alberti-Servera, Sofie Demeyer, Inge Govaerts, Toon Swings, Jolien De Bie, Olga Gielen, Marco Brociner, Lucienne Michaux, Johan Maertens, Anne Uyttebroeck, Kim De Keersmaecker, Nancy Boeckx, Heidi Segers, Jan Cools

Summary: T-cell acute lymphoblastic leukemia (T-ALL) is an aggressive leukemia characterized by chromosomal rearrangements and somatic mutations in protein-coding regions. Most T-ALL cases have activating mutations in NOTCH1 and other genes related to signaling and regulation. Single-cell DNA sequencing reveals clonal architecture and evolution in T-ALL, showing major and minor clones at diagnosis and during treatment.

BLOOD (2021)

Article Oncology

Repurposing the Antidepressant Sertraline as SHMT Inhibitor to Suppress Serine/Glycine Synthesis-Addicted Breast Tumor Growth

Shauni Lien Geeraerts, Kim Rosalie Kampen, Gianmarco Rinaldi, Purvi Gupta, Melanie Planque, Nikolaos Louros, Elien Heylen, Kaat De Cremer, Katrijn De Brucker, Stijn Vereecke, Benno Verbelen, Pieter Vermeersch, Joost Schymkowitz, Frederic Rousseau, David Cassiman, Sarah-Maria Fendt, Arnout Voet, Bruno P. A. Cammue, Karin Thevissen, Kim De Keersmaecker

Summary: Metabolic rewiring in cancer cells often leads to dependency on intracellular serine/glycine synthesis. This study repurposed the drugs sertraline and thimerosal to selectively target serine/glycine synthesis-addicted breast cancer and T-cell acute lymphoblastic leukemia cells. The combination of sertraline and mitochondrial inhibitors showed promising antitumor activity by inhibiting serine/glycine synthesis and mitochondrial metabolism simultaneously.

MOLECULAR CANCER THERAPEUTICS (2021)

Article Hematology

14q32 rearrangements deregulating BCL11B mark a distinct subgroup of T-lymphoid and myeloid immature acute leukemia

Danika Di Giacomo, Roberta La Starza, Paolo Gorello, Fabrizia Pellanera, Zeynep Kalender Atak, Kim De Keersmaecker, Valentina Pierini, Christine J. Harrison, Silvia Arniani, Martina Moretti, Nicoletta Testoni, Giovanna De Santis, Giovanni Roti, Caterina Matteucci, Renato Bassan, Peter Vandenberghe, Stein Aerts, Jan Cools, Beat Bornhauser, Jean-Pierre Bourquin, Rocco Piazza, Cristina Mecucci

Summary: The study identified a distinct subgroup of immature acute leukemias characterized by 14g32/BCL11B translocations, including AML, TIM MPAL, and ETP-ALL. These translocations activate BCL11B, whose expression behaves as a disease biomarker present at diagnosis and co-occurs with variants at FLT3 and epigenetic modulators. Transcriptome analysis revealed a specific expression signature separating BCL11B AL from AML, T-ALL, and ETP-ALL, with an ex vivo drug-sensitivity profile identifying effective antileukemic compounds.

BLOOD (2021)

Article Oncology

PSEN1-selective gamma-secretase inhibition in combination with kinase or XPO-1 inhibitors effectively targets T cell acute lymphoblastic leukemia

Inge Govaerts, Cristina Prieto, Charlien Vandersmissen, Olga Gielen, Kris Jacobs, Sarah Provost, David Nittner, Johan Maertens, Nancy Boeckx, Kim De Keersmaecker, Heidi Segers, Jan Cools

Summary: In the treatment of T-ALL, combination treatment strategies using PSEN1-selective gamma-secretase inhibitor MRK-560 with other targeted agents show synergistic effects, reducing leukemia infiltration and providing survival benefits.

JOURNAL OF HEMATOLOGY & ONCOLOGY (2021)

Article Hematology

Optimizing the diagnostic workflow for acute lymphoblastic leukemia by optical genome mapping

Katrina Rack, Jolien De Bie, Genevieve Ameye, Olga Gielen, Sofie Demeyer, Jan Cools, Kim De Keersmaecker, Joris R. Vermeesch, Johan Maertens, Heidi Segers, Lucienne Michaux, Barbara Dewaele

Summary: Acute lymphoblastic leukemia (ALL) is a malignant disease that can be divided into distinct subtypes based on clinical and genomic features. Traditional diagnostic methods are laborious and costly. This study applied optical genome mapping (OGM) to diagnose ALL and found that OGM can accurately detect common genomic abnormalities, improve the detection rate and cytogenetic resolution, and reduce turnaround time.

AMERICAN JOURNAL OF HEMATOLOGY (2022)

Meeting Abstract Hematology

Loss of the Base Excision Repair Gene Apex1 Leads to Dysfunctional Adult Hematopoietic Stem and Progenitor Cells

Samantha Zaunz, Lukas Lauwereins, Manmohan Bajaj, Beatriz Guapo Neves, Francheska Cadacio, Lana Cleuren, Celine Notredame, Jurgen Marteijn, Kim De Keersmaecker, Catherine M. Verfaillie

BLOOD (2021)

Article Biotechnology & Applied Microbiology

Exploitation of the ribosomal protein L10 R98S mutation to enhance recombinant protein production in mammalian cells

Benno Verbelen, Tiziana Girardi, Sergey O. Sulima, Stijn Vereecke, Paulien Verstraete, Jelle Verbeeck, Jonathan Royaert, Sonia Cinque, Lorenzo Montanaro, Marianna Penzo, Maya Imbrechts, Nick Geukens, Thomas Geuens, Koen Dierckx, Daniele Pepe, Kim Kampen, Kim De Keersmaecker

Summary: This study presents a novel approach to improve protein yields in mammalian cells by directly engineering the cellular translation machinery. The introduction of RPL10-R98S mutation was found to enhance translation levels and fidelity, reduce proteasomal activity, and increase the production of recombinant proteins. However, the extent of production gain depends on culture conditions, cell type, and the nature of the expressed protein.

ENGINEERING IN LIFE SCIENCES (2022)

Article Hematology

HEATR3 variants impair nuclear import of uL18 (RPL5) and drive Diamond-Blackfan anemia

Marie-Francoise O'donohue, Lydie Da Costa, Marco Lezzerini, Sule Unal, Clement Joret, Marije Bartels, Eva Brilstra, Marijn Scheijde-Vermeulen, Ludivine Wacheul, Kim De Keersmaecker, Stijn Vereecke, Veerle Labarque, Manon Saby, Sophie D. Lefevre, Jessica Platon, Nathalie Montel-Lehry, Nathalie Laugero, Eric Lacazette, Koen van Gassen, Riekelt H. Houtkooper, Pelin Ozlem Simsek-Kiper, Thierry Leblanc, Nese Yarali, Arda Cetinkaya, Nurten A. Akarsu, Pierre-Emmanuel Gleizes, Denis L. J. Lafontaine, Alyson W. MacInnes

Summary: The study reports that individuals with biallelic HEATR3 variants exhibit bone marrow failure, short stature, dysmorphic features, and intellectual disability, similar to Diamond-Blackfan anemia. These variants destabilize a protein important for nuclear import, impacting ribosomal subunit formation and p53 tumor suppressor stabilization.

BLOOD (2022)

Article Oncology

Transcription factor NKX2-1 drives serine and glycine synthesis addiction in cancer

Elien Heylen, Paulien Verstraete, Linde Van Aerschot, Shauni L. Geeraerts, Tom Venken, Kalina Timcheva, David Nittner, Jelle Verbeeck, Jonathan Royaert, Marion Gijbels, Anne Uyttebroeck, Heidi Segers, Diether Lambrechts, Jan Cools, Kim De Keersmaecker, Kim R. Kampen

Summary: This study identifies the transcription factor NKX2-1 as a driver of serine/glycine synthesis addiction in cancer cells. NKX2-1 binds and transcriptionally upregulates serine/glycine synthesis enzyme genes, enabling cells expressing NKX2-1 to proliferate and invade in serine/glycine-depleted conditions. The findings reveal the unique metabolic rewiring of NKX2-1-driven cancers and provide possibilities for new therapeutic strategies.

BRITISH JOURNAL OF CANCER (2023)

Review Biochemistry & Molecular Biology

Drivers of de novo Serine/Glycine synthesis in acute leukemia

Paulien Verstraete, Kim De Keersmaecker, Kim Rosalie Kampen

Summary: Cancer cells increase their production of serine and glycine through metabolic rewiring, specifically through upregulation of de novo serine/glycine synthesis. This review focuses on the upregulation of endogenous serine/glycine production in acute leukemia, including T-cell acute leukemia (T-ALL) and acute myeloid leukemia (AML). Genetic lesions directly impacting serine/glycine addiction in acute leukemia have been identified, along with indirect regulation of de novo serine/glycine synthesis.

FEBS LETTERS (2023)

Article Cell & Tissue Engineering

APEX1 Nuclease and Redox Functions are Both Essential for Adult Mouse Hematopoietic Stem and Progenitor Cells

Samantha Zaunz, Jonathan De Smedt, Lukas Lauwereins, Lana Cleuren, Charlie Laffeber, Manmohan Bajaj, Joyce H. G. Lebbink, Jurgen A. Marteijn, Kim De Keersmaecker, Catherine Verfaillie

Summary: APEX1 plays a crucial role in adult regenerative hematopoiesis, with its nuclease and redox domains impacting proliferating HSPCs differently.

STEM CELL REVIEWS AND REPORTS (2023)

Meeting Abstract Hematology

UNRAVELLING DRUG RESISTANCE AND SENSITIZATION TO PROTEASOME INHIBITORS USING GENOME-WIDE CRISPR-CAS9 KNOCKOUT SCREENING.

Sophie Vlayen, Marino Caruso, Kim De Keersmaecker, Dirk Daelemans, Michel Delforge

EXPERIMENTAL HEMATOLOGY (2023)

Meeting Abstract Hematology

APEX1 NUCLEASE AND REDOX FUNCTIONS ARE BOTH ESSENTIAL FOR ADULT HEMATOPOIETIC STEM AND PROGENITOR CELLS.

Samantha Zaunz, Lukas Lauwereins, Jonathan De Smedt, Lana Cleuren, Manmohan Bajaj, Jurgen Marteijn, Kim De Keersmaecker, Catherine Verfaillie

EXPERIMENTAL HEMATOLOGY (2022)

Article Hematology

Monitoring of Leukemia Clones in B-cell Acute Lymphoblastic Leukemia at Diagnosis and During Treatment by Single-cell DNA Amplicon Sequencing

Sarah Meyers, Llucia Alberti-Servera, Olga Gielen, Margot Erard, Toon Swings, Jolien De Bie, Lucienne Michaux, Barbara Dewaele, Nancy Boeckx, Anne Uyttebroeck, Kim De Keersmaecker, Johan Maertens, Heidi Segers, Jan Cools, Sofie Demeyer

Summary: This study used single cell-targeted DNA sequencing to evaluate the clonal heterogeneity of B-ALL and found that half of the cases showed multiple subclones at diagnosis. During chemotherapy treatment, leukemia clones disappeared and even rare mutant cells were easily detectable by single cell-targeted DNA sequencing.

HEMASPHERE (2022)

Review Endocrinology & Metabolism

The ins and outs of serine and glycine metabolism in cancer

Shauni L. Geeraerts, Elien Heylen, Kim De Keersmaecker, Kim R. Kampen

Summary: Cancer cells reprogram their metabolism to hyperactivate serine and glycine synthesis, relying on de novo production and genetic alterations to enhance their survival and proliferation. Serine and glycine synthesis play a crucial role in cancer progression, contributing to macromolecule synthesis, oxidative stress neutralization, and regulation of biological processes like methylation.

NATURE METABOLISM (2021)

No Data Available